The instant disclosure provides a composition comprising a capsule and a fill formulation for lipophilic salts of PDE5 inhibitors. Embodiments of the fill formulation contain a liquid, lipid vehicle in which the active ingredient is dissolved and present
-
Paragraph 074; 075
(2019/05/15)
PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS OF SILDENAFIL
The present invention is concerned with new pharmaceutically acceptable salts of sildenafil and new polymorphic forms thereof, processes for preparing the new pharmaceutically acceptable salts and new polymorphic forms, pharmaceutical compositions contain
-
Page/Page column 23
(2008/06/13)
More Articles about upstream products of 252920-86-8